Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiji Yoshimura

Showing results (211-220 of 297) with videos related to

Pageof 30
Sort By:
Pharmacogenomics|October 16, 2008
Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophreniaMasashi Ikeda, Yoshio Yamanouchi, Yoko Kinoshita, et al.
Journal of Affective Disorders|August 20, 2023
Triple network connectivity changes in patients with major depressive disorder versus healthy controls via structural network imaging after electroconvulsive therapy treatmentEnkmurun Chibaatar, Keita Watanabe, Patrick M Quinn, et al.
Journal of Integrative Neuroscience|February 1, 2023
Comparison of Serum Metabolomics Pathways and Patterns between Patients with Major Depressive Disorder with and without Type 2 Diabetes Mellitus: An Exploratory StudyNaomichi Okamoto, Takashi Hoshikawa, Atsuko Ikenouchi, et al.
Human Psychopharmacology|August 21, 2010
No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrationsReiji Yoshimura, Wakako Umene-Nakano, Nobuhisa Ueda, et al.
Scientific Reports|November 9, 2018
Brain structural connectivity and neuroticism in healthy adultsIssei Ueda, Shingo Kakeda, Keita Watanabe, et al.
Plos One|November 1, 2018
Effect of single caffeine intake on neuropsychological functions in healthy volunteers: A double-blind placebo-controlled studyYuki Konishi, Hikaru Hori, Kenta Ide, et al.
CNS Spectrums|August 14, 2012
Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD)Asuka Katsuki, Reiji Yoshimura, Taro Kishi, et al.
Psychopharmacology|July 11, 2006
Effects of repeated milnacipran administration on brain serotonergic and noradrenergic functions in healthy volunteersAtsushi Soya, Takeshi Terao, Mami Nakajima, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 30, 2010
Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosusAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Tatsuya Okamoto, et al.
Neuropsychiatric Disease and Treatment|November 7, 2019
A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorderAsuka Katsuki, Shingo Kakeda, Keita Watanabe, et al.
Pageof 30

Showing results (211-220 of 297) with videos related to

Sort By:
Pageof 30
Pharmacogenomics|October 16, 2008
Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophreniaMasashi Ikeda, Yoshio Yamanouchi, Yoko Kinoshita, et al.
Journal of Affective Disorders|August 20, 2023
Triple network connectivity changes in patients with major depressive disorder versus healthy controls via structural network imaging after electroconvulsive therapy treatmentEnkmurun Chibaatar, Keita Watanabe, Patrick M Quinn, et al.
Journal of Integrative Neuroscience|February 1, 2023
Comparison of Serum Metabolomics Pathways and Patterns between Patients with Major Depressive Disorder with and without Type 2 Diabetes Mellitus: An Exploratory StudyNaomichi Okamoto, Takashi Hoshikawa, Atsuko Ikenouchi, et al.
Human Psychopharmacology|August 21, 2010
No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrationsReiji Yoshimura, Wakako Umene-Nakano, Nobuhisa Ueda, et al.
Scientific Reports|November 9, 2018
Brain structural connectivity and neuroticism in healthy adultsIssei Ueda, Shingo Kakeda, Keita Watanabe, et al.
Plos One|November 1, 2018
Effect of single caffeine intake on neuropsychological functions in healthy volunteers: A double-blind placebo-controlled studyYuki Konishi, Hikaru Hori, Kenta Ide, et al.
CNS Spectrums|August 14, 2012
Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD)Asuka Katsuki, Reiji Yoshimura, Taro Kishi, et al.
Psychopharmacology|July 11, 2006
Effects of repeated milnacipran administration on brain serotonergic and noradrenergic functions in healthy volunteersAtsushi Soya, Takeshi Terao, Mami Nakajima, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 30, 2010
Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosusAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Tatsuya Okamoto, et al.
Neuropsychiatric Disease and Treatment|November 7, 2019
A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorderAsuka Katsuki, Shingo Kakeda, Keita Watanabe, et al.
Pageof 30